Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-dily)diimino)bis(2,4,6-triiodobenzoic Acid)
2. B 10610
3. B-10610
4. Bc 17
5. Bc-17
6. Endobil
7. Iodoxamate
8. Iodoxamic Acid, Calcium Salt
9. Iodoxamic Acid, Magnesium Salt
10. Iodoxamid
11. Iodoxamidic Acid
12. Iodoxaminic Acid
1. Videocolangio
2. Endomirabil
3. 31127-82-9
4. Endobil
5. Iodoxamid
6. Sq 21982
7. Bc-17
8. B 10610
9. B-10610
10. Ns1y283hw4
11. 3,3'-(ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodobenzoic Acid)
12. Benzoic Acid, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodo-
13. Cholevue
14. Sq-21982
15. Iodoxamsaeure
16. Iodoxamsaeure [german]
17. Acido Iodoxamico
18. Acide Iodoxamique
19. Acido Iodossamico
20. Acido Iodossamico [dcit]
21. Acidum Iodoxamicum
22. Acide Iodoxamique [inn-french]
23. Acido Iodoxamico [inn-spanish]
24. Acidum Iodoxamicum [inn-latin]
25. Einecs 250-478-1
26. Brn 2801368
27. Unii-ns1y283hw4
28. Endobil (tn)
29. Iodoxamic Acid [usan:inn:ban:jan]
30. 4,7,10,13-tetraoxahexadecane-1,16-dioyl-bis(3-carboxytriiodoanilide)
31. Dsstox_cid_31499
32. Dsstox_rid_97384
33. Iodoxamic Acid [ii]
34. Dsstox_gsid_57710
35. Iodoxamic Acid [inn]
36. Iodoxamic Acid [jan]
37. Iodoxamic Acid [usan]
38. Schembl377402
39. Iodoxamic Acid [mart.]
40. Chembl1615487
41. Dtxsid4057710
42. Iodoxamic Acid [who-dd]
43. Chebi:31707
44. Iodoxamic Acid (jan/usan/inn)
45. Tox21_113933
46. Db13539
47. Benzoic Acid, 3,3'-(ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodo-
48. Ncgc00262940-01
49. 3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic Acid
50. Cas-31127-82-9
51. D01312
52. Q6062332
Molecular Weight | 1287.9 g/mol |
---|---|
Molecular Formula | C26H26I6N2O10 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 19 |
Exact Mass | 1287.5856 g/mol |
Monoisotopic Mass | 1287.5856 g/mol |
Topological Polar Surface Area | 170 Ų |
Heavy Atom Count | 44 |
Formal Charge | 0 |
Complexity | 868 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AC - Watersoluble, hepatotropic x-ray contrast media
V08AC01 - Iodoxamic acid
ABOUT THIS PAGE
68
PharmaCompass offers a list of Iodoxamic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iodoxamic Acid manufacturer or Iodoxamic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iodoxamic Acid manufacturer or Iodoxamic Acid supplier.
PharmaCompass also assists you with knowing the Iodoxamic Acid API Price utilized in the formulation of products. Iodoxamic Acid API Price is not always fixed or binding as the Iodoxamic Acid Price is obtained through a variety of data sources. The Iodoxamic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Iodoxamic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iodoxamic Acid, including repackagers and relabelers. The FDA regulates Iodoxamic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iodoxamic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iodoxamic Acid supplier is an individual or a company that provides Iodoxamic Acid active pharmaceutical ingredient (API) or Iodoxamic Acid finished formulations upon request. The Iodoxamic Acid suppliers may include Iodoxamic Acid API manufacturers, exporters, distributors and traders.
Iodoxamic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iodoxamic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iodoxamic Acid GMP manufacturer or Iodoxamic Acid GMP API supplier for your needs.
A Iodoxamic Acid CoA (Certificate of Analysis) is a formal document that attests to Iodoxamic Acid's compliance with Iodoxamic Acid specifications and serves as a tool for batch-level quality control.
Iodoxamic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Iodoxamic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iodoxamic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Iodoxamic Acid EP), Iodoxamic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iodoxamic Acid USP).